Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Two novel quantitative trait loci affecting the variation in leaf photosynthetic capacity among soybeans.

Sakoda K, Kaga A, Tanaka Y, Suzuki S, Fujii K, Ishimoto M, Shiraiwa T.

Plant Sci. 2020 Feb;291:110300. doi: 10.1016/j.plantsci.2019.110300. Epub 2019 Nov 14.

PMID:
31928682
2.

Prediction of Cyclic Stress-Strain Property of Steels by Crystal Plasticity Simulations and Machine Learning.

Miyazawa Y, Briffod F, Shiraiwa T, Enoki M.

Materials (Basel). 2019 Nov 7;12(22). pii: E3668. doi: 10.3390/ma12223668.

3.

Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes.

Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Nishida K, Shiraiwa T, Torimoto K, Kurozumi A, Wakasugi S, Gosho M, Shimomura I, Watada H.

Diabetes Ther. 2019 Oct;10(5):1565-1575. doi: 10.1007/s13300-019-0665-8. Epub 2019 Jul 23.

4.

Genetic Diversity in Stomatal Density among Soybeans Elucidated Using High-throughput Technique Based on an Algorithm for Object Detection.

Sakoda K, Watanabe T, Sukemura S, Kobayashi S, Nagasaki Y, Tanaka Y, Shiraiwa T.

Sci Rep. 2019 May 20;9(1):7610. doi: 10.1038/s41598-019-44127-0.

5.

Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L.

Takahara M, Katakami N, Shiraiwa T, Abe K, Ayame H, Ishimaru Y, Iwamoto M, Shimizu M, Tomonaga O, Yokoyama H, Matsuoka TA, Shimomura I.

Acta Diabetol. 2019 Mar;56(3):309-319. doi: 10.1007/s00592-018-1244-6. Epub 2018 Oct 23.

PMID:
30353354
6.

Different daily glycemic profiles after switching from once-daily alogliptin plus twice-daily metformin to their once-daily fixed-dose combination in Japanese type 2 diabetic patients.

Takahara M, Shiraiwa T, Katakami N, Maeno Y, Yamamoto K, Shiraiwa Y, Yoshida Y, Matsuoka TA, Shimomura I.

Endocr J. 2019 Jan 28;66(1):11-17. doi: 10.1507/endocrj.EJ18-0313. Epub 2018 Oct 11.

7.

Correction to: Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ).

Ishii H, Shin K, Tosaki T, Haga T, Nakajima Y, Shiraiwa T, Watanabe N, Koizumi M, Nakajima H, Okada S, Mashitani T, Mohri T, Akai Y.

Diabetes Ther. 2018 Aug;9(4):1719. doi: 10.1007/s13300-018-0459-4.

8.

Parameterization of the vertical distribution of leaf area index (LAI) in rice (Oryza sativa L.) using a plant canopy analyzer.

Hirooka Y, Homma K, Shiraiwa T.

Sci Rep. 2018 Apr 23;8(1):6387. doi: 10.1038/s41598-018-24369-0.

9.

Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ).

Ishii H, Shin K, Tosaki T, Haga T, Nakajima Y, Shiraiwa T, Watanabe N, Koizumi M, Nakajima H, Okada S, Mashitani T, Mohri T, Akai Y.

Diabetes Ther. 2018 Jun;9(3):1001-1019. doi: 10.1007/s13300-018-0414-4. Epub 2018 Mar 29. Erratum in: Diabetes Ther. 2018 Aug;9(4):1719.

10.

Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.

Kurozumi A, Okada Y, Satoh H, Inoue I, Chimori H, Akita E, Shiraiwa T, Fujitani Y, Mita T, Gosho M, Watada H.

Endocr J. 2018 Apr 26;65(4):415-425. doi: 10.1507/endocrj.EJ17-0386. Epub 2018 Jan 25.

11.

Improved treatment satisfaction and medication adherence after readjusting oral medication regimens with the cooperation of health insurance pharmacy in type 2 diabetic patients in Japan.

Ogawa N, Takahara M, Shiraiwa T, Yamamoto M, Yamamoto K, Doi M, Yoshida Y, Gotou S.

J Pharm Health Care Sci. 2017 Dec 6;3:27. doi: 10.1186/s40780-017-0096-5. eCollection 2017.

12.

Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Gosho M, Shimomura I, Watada H.

Diabetes Ther. 2017 Oct;8(5):1135-1146. doi: 10.1007/s13300-017-0309-9. Epub 2017 Sep 20.

13.

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I; UTOPIA study investigators.

Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 1.

14.

Marked recovery from glucotoxicity of β-cell function after medical nutrition therapy without pharmacotherapy in type 2 diabetic outpatients with extreme hyperglycemia: a pilot retrospective study.

Takahara M, Shiraiwa T, Katakami N, Matsuoka TA, Shimomura I.

Endocr J. 2017 Nov 29;64(11):1125-1129. doi: 10.1507/endocrj.EJ17-0222. Epub 2017 Aug 25.

15.

Once-weekly oral antidiabetic agent and treatment satisfaction.

Takahara M, Shiraiwa T, Katakami N, Matsuoka TA, Shimomura I.

Curr Med Res Opin. 2017 Nov;33(11):2093-2094. doi: 10.1080/03007995.2017.1359519. Epub 2017 Aug 16. No abstract available.

PMID:
28737467
16.

The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Gosho M, Ishii H, Shimomura I, Watada H; SPIKE Trial Site Investigators.

Diabetes Ther. 2017 Jun;8(3):693-704. doi: 10.1007/s13300-017-0267-2. Epub 2017 May 17.

17.

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139-148.

Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Shimomura I, Watada H; Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial.

Diabetes Care. 2017 Jun;40(6):808. doi: 10.2337/dc17-er06b. Epub 2017 Apr 18. No abstract available.

18.

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Yamamoto T, Matsumoto K, Yokoyama H, Tsugawa M, Gosho M, Shimomura I, Watada H; Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial.

Diabetes Care. 2017 Jun;40(6):808. doi: 10.2337/dc17-er06a. Epub 2017 Apr 18. No abstract available.

19.

Patient Perspectives on Combination Therapy of a Once-weekly Oral Medication Plus Daily Medication for Lifestyle-related Chronic Diseases.

Takahara M, Shiraiwa T, Ogawa N, Yamamoto M, Kusuda Y, Shindo M, Hashio S, Katakami N, Matsuoka TA, Shimomura I.

Intern Med. 2017;56(6):615-620. doi: 10.2169/internalmedicine.56.7583. Epub 2017 Mar 17.

20.

Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring - The NOCTURNE Study.

Kario K, Tomitani N, Kanegae H, Ishii H, Uchiyama K, Yamagiwa K, Shiraiwa T, Katsuya T, Yoshida T, Kanda K, Hasegawa S, Hoshide S.

Circ J. 2017 Jun 23;81(7):948-957. doi: 10.1253/circj.CJ-17-0109. Epub 2017 Mar 17.

21.

Changes in carotid intima-media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Gosho M, Shimomura I, Watada H; Sitagliptin Preventive Study of Intima-media Thickness Evaluation (SPIKE) Trial.

J Diabetes Investig. 2017 Mar;8(2):254-255. doi: 10.1111/jdi.12559.

22.

The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Gosho M, Shimomura I, Watada H.

Int J Endocrinol. 2017;2017:1925305. doi: 10.1155/2017/1925305. Epub 2017 Jan 17.

23.

Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Gosho M, Shimomura I, Watada H.

Sci Rep. 2017 Jan 9;7:39965. doi: 10.1038/srep39965.

24.

Identification of large variation in the photosynthetic induction response among 37 soybean [Glycine max (L.) Merr.] genotypes that is not correlated with steady-state photosynthetic capacity.

Soleh MA, Tanaka Y, Kim SY, Huber SC, Sakoda K, Shiraiwa T.

Photosynth Res. 2017 Mar;131(3):305-315. doi: 10.1007/s11120-016-0323-1. Epub 2016 Nov 22.

PMID:
27878416
25.

Preference in time of insulin injection in type 2 diabetic patients treated with once-daily long-acting insulin analog.

Takahara M, Shiraiwa T, Katakami N, Matsuoka TA, Shimomura I.

Diabetes Obes Metab. 2016 Nov;18(11):1098-1099. doi: 10.1111/dom.12762. No abstract available.

PMID:
27502692
26.

Structures of N-acetyl-DL-isoleucine, N-acetyl-DL-alloisoleucine and their ammonium salts; role of ammonium ions in crystal structure formation.

Yajima T, Kimura M, Hori Y, Shiraiwa T.

Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Aug 1;72(Pt 4):650-7. doi: 10.1107/S2052520616007319. Epub 2016 Aug 1.

PMID:
27484385
27.

Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial.

Seino Y, Kaneko S, Fukuda S, Osonoi T, Shiraiwa T, Nishijima K, Bosch-Traberg H, Kaku K.

J Diabetes Investig. 2016 Jul;7(4):565-73. doi: 10.1111/jdi.12457. Epub 2016 Jan 23.

28.

Clinical backgrounds associated with discrepancy between subjective and objective assessments of medication adherence in Japanese type 2 diabetic patients.

Takahara M, Shiraiwa T, Ogawa N, Katakami N, Matsuoka TA, Shimomura I.

Diabetol Int. 2016 Apr 6;7(4):398-403. doi: 10.1007/s13340-016-0265-z. eCollection 2016 Dec.

29.

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Yamamoto T, Matsumoto K, Yokoyama H, Tsugawa M, Gosho M, Shimomura I, Watada H; Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial.

Diabetes Care. 2016 Mar;39(3):455-64. doi: 10.2337/dc15-2145. Epub 2016 Jan 28. Erratum in: Diabetes Care. 2017 Jun;40(6):808.

PMID:
26822324
30.

Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallel-group trial.

Kaku K, Kiyosue A, Ono Y, Shiraiwa T, Kaneko S, Nishijima K, Bosch-Traberg H, Seino Y.

J Diabetes Investig. 2016 Jan;7(1):76-84. doi: 10.1111/jdi.12367. Epub 2015 Jul 14. Erratum in: J Diabetes Investig. 2016 Mar;7(2):279.

31.

Variations in the associations of taste-related words with foods in diabetic patients in Japan according to gender, age, and geographical region: a multicenter study conducted in seven regions of Japan.

Takahara M, Shiraiwa T, Abe K, Ishimaru Y, Iwamoto M, Shimizu M, Tomonaga O, Yokoyama H.

Diabetol Int. 2016 Jan 13;7(3):314-320. doi: 10.1007/s13340-015-0252-9. eCollection 2016 Sep.

32.

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).

Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Shimomura I, Watada H; Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial.

Diabetes Care. 2016 Jan;39(1):139-48. doi: 10.2337/dc15-0781. Epub 2015 Dec 1. Erratum in: Diabetes Care. 2017 Jun;40(6):808.

PMID:
26628419
33.

Factors underlying genotypic differences in the induction of photosynthesis in soybean [Glycine max (L.) Merr].

Soleh MA, Tanaka Y, Nomoto Y, Iwahashi Y, Nakashima K, Fukuda Y, Long SP, Shiraiwa T.

Plant Cell Environ. 2016 Mar;39(3):685-93. doi: 10.1111/pce.12674. Epub 2016 Jan 12.

34.

Carbonaceous aerosol tracers in ice-cores record multi-decadal climate oscillations.

Seki O, Kawamura K, Bendle JA, Izawa Y, Suzuki I, Shiraiwa T, Fujii Y.

Sci Rep. 2015 Sep 28;5:14450. doi: 10.1038/srep14450.

35.

Vertical distribution of dioxins in soil of Bien Hoa airbase, Vietnam.

Huyen DT, Igarashi T, Shiraiwa T.

Springerplus. 2015 Jun 30;4:300. doi: 10.1186/s40064-015-1064-x. eCollection 2015.

36.

Seed yield and its components of indeterminate and determinate lines in recombinant inbred lines of soybean.

Kato S, Fujii K, Yumoto S, Ishimoto M, Shiraiwa T, Sayama T, Kikuchi A, Nishio T.

Breed Sci. 2015 Mar;65(2):154-60. doi: 10.1270/jsbbs.65.154. Epub 2015 Mar 1.

37.

Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin.

Takahara M, Shiraiwa T, Matsuoka TA, Katakami N, Shimomura I.

Endocr J. 2015;62(1):77-86. doi: 10.1507/endocrj.EJ14-0335. Epub 2014 Oct 17.

38.

Efficacy of adding once-daily insulin glulisine in Japanese type 2 diabetes patients treated with insulin glargine and sitagliptin.

Takahara M, Shiraiwa T, Katakami N, Matsuoka TA, Shimomura I.

Diabetes Technol Ther. 2014 Oct;16(10):633-9. doi: 10.1089/dia.2014.0075. Epub 2014 Jun 20.

PMID:
24949654
39.

Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial.

Takahara M, Shiraiwa T, Shindo M, Arai A, Kusuda Y, Katakami N, Kaneto H, Matsuoka TA, Shimomura I.

Hypertens Res. 2014 Sep;37(9):852-7. doi: 10.1038/hr.2014.86. Epub 2014 Apr 17.

PMID:
24739538
40.

A major and stable QTL associated with seed weight in soybean across multiple environments and genetic backgrounds.

Kato S, Sayama T, Fujii K, Yumoto S, Kono Y, Hwang TY, Kikuchi A, Takada Y, Tanaka Y, Shiraiwa T, Ishimoto M.

Theor Appl Genet. 2014 Jun;127(6):1365-74. doi: 10.1007/s00122-014-2304-0. Epub 2014 Apr 10.

PMID:
24718925
41.

Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE).

Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Yamamoto T, Matsumoto K, Yokoyama H, Tsugawa M, Gosho M, Shimomura I, Watada H.

Diabetol Metab Syndr. 2014 Mar 10;6(1):35. doi: 10.1186/1758-5996-6-35.

42.

Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin.

Takahara M, Shiraiwa T, Katakami N, Kaneto H, Matsuoka TA, Shimomura I.

Endocr J. 2014;61(5):447-56. Epub 2014 Feb 22.

43.

Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).

Katakami N, Mita T, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Watada H, Shimomura I; Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis Trial.

J Atheroscler Thromb. 2013;20(12):893-902. Epub 2013 Aug 20.

44.

Regular insulin, rather than rapid-acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus.

Kuroda A, Kaneto H, Kawashima S, Sakamoto K, Takahara M, Shiraiwa T, Yasuda T, Katakami N, Matsuoka TA, Shimomura I, Matsuhisa M.

J Diabetes Investig. 2013 Jan 29;4(1):78-81. doi: 10.1111/j.2040-1124.2012.00231.x. Epub 2012 Aug 21.

45.

Efficacy of liraglutide therapy in Japanese type 2 diabetic patients insufficiently controlled with basal-supported oral therapy.

Takahara M, Shiraiwa T, Ohtoshi K, Kaneto H, Katakami N, Matsuoka TA, Shimomura I.

J Diabetes Investig. 2012 Dec 20;3(6):510-6. doi: 10.1111/j.2040-1124.2012.00223.x.

46.

Efficacy of sitagliptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy.

Takahara M, Shiraiwa T, Kaneto H, Katakami N, Matsuoka TA, Shimomura I.

Endocr J. 2012;59(12):1131-6. Epub 2012 Jul 27.

47.

Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy.

Shiraiwa T, Takahara M, Kaneto H, Miyatsuka T, Yamamoto K, Yoshiuchi K, Sakamoto K, Matsuoka TA, Matsuhisa M, Yamasaki Y, Shimomura I.

Diabetes Res Clin Pract. 2010 Dec;90(3):e91-2. doi: 10.1016/j.diabres.2010.09.022. Epub 2010 Oct 27. No abstract available.

PMID:
21030103
48.

Preparation of optically active allothreonine by separating from a diastereoisomeric mixture with threonine.

Yajima T, Ichimura S, Horii S, Shiraiwa T.

Biosci Biotechnol Biochem. 2010;74(10):2106-9. Epub 2010 Oct 7.

49.

Improvement of psoriatic arthritis by pioglitazone treatment in a type 2 diabetic patient.

Takahara M, Shiraiwa T, Kaneto H, Yasuda T, Kuroda A, Sakamoto F, Naka T, Miyashita K, Sakamoto K, Matsuoka T, Shimomura I, Matsuhisa M.

Diabetes Res Clin Pract. 2010 Oct;90(1):e9-e10. doi: 10.1016/j.diabres.2010.05.020. Epub 2010 Jun 17. No abstract available.

PMID:
20816261
50.

Supplemental Content

Loading ...
Support Center